Following the 2008 recession and heightened scrutiny over executive rewards, there is little surprise that total executive compensation for the executives in IBO’s annual executive compensation tables declined last year. In fiscal 2009, total average compensation for the 57 executives at 42 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO […]
The gloom has lifted, according to the latest results of IBO’s Business Climate Survey. In contrast to the fall 2009 Business Climate Survey, conducted in October 2009 (see IBO 10/15/09), when 17% of respondents expected sales to decline in the next six months, not one Survey participant in this spring’s Survey expects sales to decline. […]
San Diego, CA 5/6/10; San Diego, CA 5/12/10—Sequenom has announced that it expects to raise $51.6 million through a private placement of common stock. The company has entered into an agreement to issue and sell 12,435,000 shares of common stock at $4.15 per share to certain investors. Earlier in the month, Sequenom announced it plans […]
Positive corporate earnings and acquisitions boosted US equity markets in April, as the Dow Jones Industrial Average, S&P 500 and NASDAQ ended the month up 1.4%, 1.5% and 2.6%, respectively. Momentum was furthered by rising home sales, manufacturing data and consumer sentiment, along with optimistic comments from the Federal Reserve. However, investors grew apprehensive following […]
Company Announcements Illumina Board member Jack Goldstein will not stand for re-election in May. Thermo Fisher Scientific completed a 35,000-square-foot addition to its Pierce facility in Rockford, Illinois. In February, Thermo Fisher Scientific opened an additional facility in Cheshire, UK, adding 60 new jobs. The facility serves as a Center of Excellence for its Anatomical […]
New laboratory construction in late 2009 and early 2010 was driven by both public and private expenditures. New laboratory plans included a continuing flow of bioscience university projects in the US, as well as government-coordinated national projects worldwide. R&D laboratories for agricultural biotechnology companies and new labs for consumer products companies were also announced. Among […]
Fourth-quarter sales for the IBO Lab Equipment/Consumables Index climbed 8.3% to $922.96 million, including 2.4% growth from currency. Median growth was 6.3%. Operating profit grew 14.7% to $305.37 million. Operating margins improved 190 basis points to 33.1% of sales. The median operating profit margin was 17.5%. For the year, Index sales slipped 1.6% to $3,478.49 […]
In the February 15 issue, IBO detailed R&D reorganizations at major pharmaceutical companies. Since then, Merck has announced its 2009 results, including a new Merger Restructuring Program. The Program addresses the combined operations of Merck and Schering-Plough, which Merck acquired in November 2009. Merck plans to cut 15% of its 100,000 employees by the end […]
Financials for the IBO Laboratory Sales Index have been updated from the numbers that appeared in the February 28 issue now that all the companies in the Index, except for Oxford Instruments, have reported calendar-year fourth-quarter and year-end results. For the fourth quarter, Laboratory Sales Index sales grew 6.9% to $4,985.89 million, including 5.1% growth […]
The US equity markets enjoyed another relatively unabated month as the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 5.1%, 5.9% and 7.1%, respectively. The Dow hit an 18-month high on March 30, not far from the 11,000 mark. While there are a number of positive economic data to support the recovery, such as […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
